Sbir phase II: novel camera-projector device leveraging non-invasive registration and projected augmented reality for navigation in minimally invasive spine procedures

Active Cooperative Agreement Awarded

Award ID
2507300
Recipient
Awarding agency
Obligated
$1,250,000

Award facts

Completion date 63% complete
Place of performance
Palo Alto, CA 94301, USA

Award details come from USAspending.gov.

About this award

Award Details: Illuminant Surgical Inc. received a $1.25 million Cooperative Agreement from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on August 15, 2025, for the SBIR Phase II project titled "Novel Camera-Projector Device Leveraging Non-Invasive Registration and Projected Augmented Reality for Navigation in Minimally Invasive Spine Procedures." The project extends through July 31, 2027, and is being performed in Palo Alto, California.

Products and Services: This Phase II project focuses on developing and validating a novel surgical navigation technology that combines 3D sensing and light projection to enable real-time image-guided procedures. The deliverables include advanced software algorithms that analyze patient position and anatomy to accurately align medical images with the patient's body in real time, a novel display system that projects surgical navigation information directly onto the patient's skin surface, and bench validation testing to measure system accuracy and clinical readiness. The technology aims to provide surgeons with direct visualization of internal anatomy and surgical tool positioning during minimally invasive spine procedures, with sufficient precision to reduce complications, improve surgical outcomes, and lower operational costs compared to existing navigation systems—particularly benefiting smaller hospitals and outpatient surgery centers that cannot afford more complex, costly navigation tools.

Description

Abstract
The broader impact/commercial potential of this small business innovation research (SBIR) phase II project is a novel means for providing in hospital image-guided navigation to improve the accuracy and affordability of surgical procedures. Surgical procedures, notably those involving the spine, require high levels of precision. Existing navigation tools implent more complex, higher cost disposable components, or invasive technologies that prevent greater widespread adoption especially in smaller hospitals and outpatient centers. This project aims to commercialize a novel technology that enables surgeons to project images of patient?S internal anatomy and various tool positioning directly onto to the patient?S body surface for direct visualization in real time with sufficient precision for specific operational procedures. By improving surgical accuracy and reducing complications such as misplaced implants or reoperations the objective is to improve patient outcomes with a modern navigation tool while reducing operational and hospital costs. This small business innovation research (SBIR) phase II project focuses on developing the technical components needed for a new surgical navigation method that combines 3D sensing and light projection in an interactive and responsive manner. The technology development includes furthering software development that enables the system to analyze the position of the patient and anatomy in real-time and accurately align medical images with the patient?S body. The project will also include designing a novel manner of displaying surgical information on the skin surface in a clear and helpful manner for the surgeon within accuracy, latency and human factors requirements for clinical use. Bench validation testing will be performed to measure how accurately the system matches images to the patient, with the goal of meeting or exceeding industry accuracy standards. The end objective of this project is an operating validated prototype tested in a controlled laboratory setting, suitable for more advanced testing and commercial and clinical pilot studies. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.- subawards are not planned for this award.

Quick answers

Who received award 2507300?

2507300 was awarded to Illuminant Surgical Inc. by National Science Foundation on August 15, 2025.

How much is award 2507300 worth?

$1,250,000 has been obligated on 2507300.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award